Quest Management Inc. (OTCMKTS:QSMG) has signed an important agreement to acquire Sanavida, a telemedicine platform. The acquisition sent a shockwave through the stock this week with a massive jump in activity that sent volume peaking at 258k mid-day. QSMG has a market cap of 8.40M, and with this new entry into a rising sector, investors should take notice.
The acquisition of Sanavida (www.sanavida.online) will serve as a beachhead into the Telemedicine market for QSMG. Sanavida is a cutting edge, new entrant in the Telemedicine field and could mean a big boost in revenues. Furthermore, the new platform could serve to expand QSMG’s market footprint and brand name.
Quest Management Inc. (OTCMKTS:QSMG) chose to acquire Sanvida because of the growing healthcare marketplace and the unique niche opportunity the platform represents. Available in both Spanish and English, Sanavida is a solution to the health crisis posed by the volatility and complications of the national Health Insurance debate. For individuals without Health Insurance, a family can subscribe to a service which includes, for a low monthly fee: no cost, face to face online consultation by a physician, 24/7 for all family members with an average 8 minute wait; Discounted medical visits, prescriptions, diabetic supplies, up to 75% off using a membership card; counseling for stress, depression, anxiety, marital issues, work conflict, anger, grief, loss, drug and alcohol abuse; and more.
Subscribe below and we’ll keep you on top of what’s happening before $QSMG stock makes its next move.
Quest Management Inc. (OTCMKTS:QSMG) has previously announced the signing of a Stock Purchase Agreement between QSMG’s President, Mr. Dmitrij Ozolins and TN3 LLC, a Wyoming limited liability company, whereby TN3 agreed to acquire shares of common stock owned by Mr. Ozolins, which represents all of the shares owned by Mr. Ozolins. The parties changed of control on April 15, 2017, which coincided with the move in the share price. At the time of closing, Mr. Dan Martin, the CEO and controlling shareholder of TN3, will be appointed as a member of the Board of Directors of Quest. Mr. Martin, thereafter, intends to cause TN3 to vend into QSMG, TN3’s assets, subsidiaries and divisions in equity swap transactions.
TN3 has numerous diversified initiatives created specifically for development within an environment such as QSMG. One initiative is in the Biotech sector, which includes Cancer treatment technology currently being commercialized in partnership with a top US hospital in the United States. The work includes patents achieved in the area of immunotherapy for brain tumor patients. This Biotech initiative also includes scientifically advanced anti-aging and other human focused technologies. These have significant market potential for sales and one patent filed, with multiple subsequent patents expected, and feature the participation of multiple, notable scientists.
TN3 also has a rapidly expanding subsidiary that provides telemedicine (the ability of individuals to remotely access medical advice) to both English and Spanish speaking people living in the U.S. TN3 has other traditional business interests, including durable goods distribution, which will be discussed at a later time.
Presently, agreements for the acquisition of these assets are being negotiated, and QSMG will disclose them to the public in the near future.
Quest has strategically positioned itself to tackle an underserved community and marketplace. This will result in appreciable shareholder value. Quest Management Inc. (OTCMKTS:QSMG), the trade-able public entity, is starting to price the value of the shares correctly. We know that the large volume this week will not be the only one, but should serve as a signal to watch how this new acquisition will settle in as short and long-term investors grab a stake in its future. For more news on QSMG stock and other fast-moving penny stocks, please subscribe to OracleDispatch.com below.